475 related articles for article (PubMed ID: 10231044)
1. Forearm bone density in users of Depo-Provera as a contraceptive method.
Bahamondes L; Perrotti M; Castro S; Faúndes D; Petta C; Bedone A
Fertil Steril; 1999 May; 71(5):849-52. PubMed ID: 10231044
[TBL] [Abstract][Full Text] [Related]
2. A prospective comparison of bone density in adolescent girls receiving depot medroxyprogesterone acetate (Depo-Provera), levonorgestrel (Norplant), or oral contraceptives.
Cromer BA; Blair JM; Mahan JD; Zibners L; Naumovski Z
J Pediatr; 1996 Nov; 129(5):671-6. PubMed ID: 8917232
[TBL] [Abstract][Full Text] [Related]
3. Bone density among long-term users of medroxyprogesterone acetate as a contraceptive.
Paiva LC; Pinto-Neto AM; Faundes A
Contraception; 1998 Dec; 58(6):351-5. PubMed ID: 10095971
[TBL] [Abstract][Full Text] [Related]
4. Timing of onset of contraceptive effectiveness in Depo-Provera users: Part I. Changes in cervical mucus.
Petta CA; Faundes A; Dunson TR; Ramos M; DeLucio M; Faundes D; Bahamondes L
Fertil Steril; 1998 Feb; 69(2):252-7. PubMed ID: 9496338
[TBL] [Abstract][Full Text] [Related]
5. Long-term depot-medroxyprogesterone acetate and bone mineral density.
Tang OS; Tang G; Yip P; Li B; Fan S
Contraception; 1999 Jan; 59(1):25-9. PubMed ID: 10342083
[TBL] [Abstract][Full Text] [Related]
6. The effect of past use of the injectable contraceptive depot medroxyprogesterone acetate on bone mineral density in normal post-menopausal women.
Orr-Walker BJ; Evans MC; Ames RW; Clearwater JM; Cundy T; Reid IR
Clin Endocrinol (Oxf); 1998 Nov; 49(5):615-8. PubMed ID: 10197077
[TBL] [Abstract][Full Text] [Related]
7. Bone mineral density in long-term depot medroxyprogesterone acetate acceptors.
Taneepanichskul S; Intaraprasert S; Theppisai U; Chaturachinda K
Contraception; 1997 Jul; 56(1):1-3. PubMed ID: 9306024
[TBL] [Abstract][Full Text] [Related]
8. Metabolic parameter, bleeding, and weight changes in U.S. women using progestin only contraceptives.
Mainwaring R; Hales HA; Stevenson K; Hatasaka HH; Poulson AM; Jones KP; Peterson CM
Contraception; 1995 Mar; 51(3):149-53. PubMed ID: 7621683
[TBL] [Abstract][Full Text] [Related]
9. Forearm bone density in long-term users of oral combined contraceptives and depot medroxyprogesterone acetate.
Perrotti M; Bahamondes L; Petta C; Castro S
Fertil Steril; 2001 Sep; 76(3):469-73. PubMed ID: 11532466
[TBL] [Abstract][Full Text] [Related]
10. Differential effects on bone density of progestogen-only methods for contraception in premenopausal women.
Naessen T; Olsson SE; Gudmundson J
Contraception; 1995 Jul; 52(1):35-9. PubMed ID: 8521712
[TBL] [Abstract][Full Text] [Related]
11. Long-term depot medroxyprogesterone acetate (Depo-Provera) use in inner-city adolescents.
Polaneczky M; Liblanc M
J Adolesc Health; 1998 Aug; 23(2):81-8. PubMed ID: 9714170
[TBL] [Abstract][Full Text] [Related]
12. Bone density in long term users of depot medroxyprogesterone acetate.
Gbolade B; Ellis S; Murby B; Randall S; Kirkman R
Br J Obstet Gynaecol; 1998 Jul; 105(7):790-4. PubMed ID: 9692421
[TBL] [Abstract][Full Text] [Related]
13. Bone density in women receiving depot medroxyprogesterone acetate for contraception.
Cundy T; Evans M; Roberts H; Wattie D; Ames R; Reid IR
BMJ; 1991 Jul; 303(6793):13-6. PubMed ID: 1830502
[TBL] [Abstract][Full Text] [Related]
14. A comparative study of one-year weight gain among users of medroxyprogesterone acetate, levonorgestrel implants, and oral contraceptives.
Moore LL; Valuck R; McDougall C; Fink W
Contraception; 1995 Oct; 52(4):215-9. PubMed ID: 8605778
[TBL] [Abstract][Full Text] [Related]
15. Timing of onset of contraceptive effectiveness in Depo-Provera users. II. Effects on ovarian function.
Petta CA; Faúndes A; Dunson TR; Ramos M; DeLucio M; Faúndes D; Bahamondes L
Fertil Steril; 1998 Nov; 70(5):817-20. PubMed ID: 9806559
[TBL] [Abstract][Full Text] [Related]
16. [Status of bone mineral density after the long-standing application of contraception Depo-Provera].
Zeman S; Havlík P; Zemanová J; Němec D
Ceska Gynekol; 2013 Jan; 78(1):116-24. PubMed ID: 23607391
[TBL] [Abstract][Full Text] [Related]
17. A cross-sectional study of the forearm bone mineral density in long-term current users of the injectable contraceptive depot medroxyprogesterone acetate.
Viola AS; Castro S; Bahamondes MV; Fernandes A; Viola CF; Bahamondes L
Contraception; 2011 Nov; 84(5):e31-7. PubMed ID: 22018135
[TBL] [Abstract][Full Text] [Related]
18. Depo Provera: a profile of current users.
Jarman H; Kovacs GT; Westcott M
Aust N Z J Obstet Gynaecol; 1990 Feb; 30(1):74-6. PubMed ID: 2140675
[TBL] [Abstract][Full Text] [Related]
19. Decline in bone mineral density with stress fractures in a woman on depot medroxyprogesterone acetate. A case report.
Harkins GJ; Davis GD; Dettori J; Hibbert ML; Hoyt RA
J Reprod Med; 1999 Mar; 44(3):309-12. PubMed ID: 10202754
[TBL] [Abstract][Full Text] [Related]
20. Depot medroxyprogesterone acetate pioneers. A retrospective study at a North Carolina Health Department.
Potter LS; Dalberth BT; Cañamar R; Betz M
Contraception; 1997 Nov; 56(5):305-12. PubMed ID: 9437559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]